Leishmania amazonensis infection is reduced in macrophages treated with guanine ribonucleosides.
Giorgio
S
S
Departamento de Parasitologia, Instituto de Biologia, Universidade Estadual de Campinas, São Paulo, Brazil. sgiorgio@uol.com.br
Barão
S C
SC
Augusto
O
O
Kwee
J K
JK
D000276:Adjuvants, Immunologic; D000818:Animals; D002478:Cells, Cultured; D006151:Guanosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D007894:Leishmania mexicana / Q000276:immunology* / Q000502:physiology; D008262:Macrophage Activation; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000276:immunology / Q000469:parasitology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D013872:Thionucleosides / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D013872:Thionucleosides; D006151:Guanosine; C046215:8-hydroxyguanosine; C035169:8-bromoguanosine; C037031:8-thioguanosine